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Background: Chlamydia notifications continue to rise in young people in many countries and regular chlamydia
testing is an important prevention strategy. Although there have been initiatives to increase testing in primary care,
none have specifically investigated the role of practice nurses (PNs) in maximising testing rates. PNs have previously
expressed a willingness to be involved, but noted lack of support from general practitioners (GPs) as a barrier. We
sought GPs’ attitudes and opinions on PNs taking an expanded role in chlamydia testing and partner notification.
Methods: In the context of a cluster randomised trial in mostly rural towns in 4 Australian states, semi structured
interviews were conducted with 44 GPs between March 2011 and July 2012. Data relating to PN involvement in
chlamydia testing were thematically analysed using a conventional content analysis approach.
Results: The majority of GPs interviewed felt that a role for PNs in chlamydia testing was appropriate. GPs felt that
PNs had more time for patient education and advice, that patients would find PNs easier to talk to and less
intimidating than GPs, and that GPs themselves could benefit through a reduction in their workload. Although GPs
felt that PNs could be utilised more effectively for preventative health activities such as chlamydia testing, many
raised concerns about how these activities would be renumerated whilst some felt that existing workload pressures
for PNs could make it difficult for them to expand their role. Whilst some rural GPs recognised that PNs might be
well placed to conduct partner notification, they also recognised that issues of patient privacy and confidentiality
related to living in a “small town” was also a concern.
Conclusion: This is the first qualitative study to explore GPs’ views around an increased role for PNs in chlamydia
testing. Despite the concerns raised by PNs, these findings suggest that GPs support the concept and recognise
that PNs are suited to the role. However issues raised, such as funding and remuneration may act as barriers that
will need to be addressed before PNs are supported to make a contribution to increasing chlamydia testing rates
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Throughout the western world, Chlamydia trachomatis
infection (hereafter referred to as chlamydia) continues
to be of significant public health concern. Affecting
mainly young adults aged 15–29 years, chlamydia is the
most commonly diagnosed bacterial sexually transmitted
infection in the United States, Europe and also Australia,
where over 82 000 diagnoses were made in 2012 [1-3].
The development of pelvic inflammatory disease (PID)
in around 10% of women with untreated chlamydia [4]
may lead to long term sequelae including infertility, ec-
topic pregnancy, and chronic pelvic pain [5,6]. As the
majority of chlamydia infections are asymptomatic [6],
many infections will go undetected in the absence of
screening.
Annual chlamydia screening for young adults is rec-
ommended in a number of countries; however, England
is the only country currently running an organized chla-
mydia screening program [7], with other European
countries planning screening programs in the future
[8]. Australia is currently piloting an opportunistic pro-
gram of chlamydia testing in general practice – the Aus-
tralian Chlamydia Control Effectiveness Pilot (ACCEPt)
[9]. General practice in Australia, despite being well
placed to carry out screening as most young adults attend
a general practitioner (GP) at least once a year, has
low rates of testing at 12.1% in women and 4.8% in
men [8].
As part of ACCEPt, the potential role of the practice
nurse (PN) to contribute to increasing testing rates in
general practice is being investigated. Recent years have
seen growth in both the numbers of PNs and scope of
their roles in Australia. Whilst a role in preventative
and sexual health, and chlamydia testing in particular,
is not as well established as in countries such as the
United Kingdom, recent research suggests Australian
PNs may be willing to expand into this area [10-12].
There is very little research relating to PNs’ role in
chlamydia testing, but evaluations of a small pilot study
of nurse-led testing in New Zealand and partner notifi-
cation performed by PNs in the UK have shown that
such PN-led strategies may be effective [13,14]. Re-
search examining GPs views regarding PN involvement
in sexual health is limited. Recent Australian research
found a lack of support and recognition among some
GPs for an expanded PN role in sexual health care [10],
whilst in as yet unpublished research, PNs have re-
ported that they were willing to have an increased role
in chlamydia testing, but felt GP attitudes may be a bar-
rier (unpublished observations -Lorch). In this, the first
qualitative study to address the issue of chlamydia test-
ing specifically, we aim to explore GPs’ opinions and at-
titudes towards PNs taking a role in chlamydia testing
and partner notification.Methods
Setting
The Australian Chlamydia Control Effectiveness Pilot
(ACCEPt) is a randomised controlled trial of an orga-
nised program of chlamydia testing in general practice.
It aims to determine whether annual chlamydia testing
of 16–29 year old women and men can reduce the
prevalence of chlamydia. A total of 134 general practice
clinics in 54 rural areas of four Australian states, along
with 9 in metropolitan areas were enrolled. Areas were
randomised to either receive an evidence-based, multifa-
ceted intervention developed to facilitate an increase in
chlamydia testing or to continue with usual care [9]. An
optional component of the intervention arm allowed
the general practice clinics to involve PNs in chlamydia
testing. The PNs at these general practice clinics under-
went a training session and received a comprehensive
chlamydia education pack. Financial incentive payments
were made to the general practice clinics for chlamydia
tests that involved input from a PN.
Australian general practice clinics (hereafter referred to
as “clinics”) operate as small businesses. They receive the
majority of their funding from the Australian government
through the Medicare Benefits Schedule (MBS) on a fee-
per-service basis. Until recently the sole source of funding
for PNs in most clinics came from government rebates, in
the form of Medicare PN “item numbers”. These item
numbers covered a limited number of services provided
by PNs, including wound dressings, Pap smears and
immunisations. Incentive payments for the employment
of PNs were also available, but only to remote, rural and
some outer urban clinics [15]. In 2012, following the
introduction of the Practice Nurse Incentive Program
(PNIP), the incentive payments and six PN item numbers
were replaced with a single funding stream for PNs. The
PNIP is available to clinics in all geographic areas, and also
provides additional funding to rural clinics [16].Study design
Participants
At trial baseline and prior to randomisation, in depth tele-
phone interviews were conducted with GPs employed in
participating clinics. GPs were selected using purposive
sampling [17], with consideration given to geographical
location, size of the clinics, age and gender of the GP to
ensure variability of participants.Consent
GPs were contacted by telephone and invited to partici-
pate. Consent was obtained for an interview be conducted
at their convenience. The GPs who were interviewed
received a $100 voucher for their time.
Table 1 Participant characteristics





<30 years 2 (4)
30-44 years 21 (48)
45-59 years 18 (41)
>60 years 3 (7)
Location of GP
Victoria – Metro 5 (11)
Victoria – Rural 15 (34)
New South Wales 11 (25)
Queensland 10 (23)
South Australia 3 (7)
Size of practice (Number of GPs)
≤4 25 (57)
>4 19 (43)
Years in medical practice
<15 years 11 (25)
15-29 years 22 (50)
30+ years 11 (25)
Years in general practice
0-10 years 18 (41)
11-20 years 13 (29)
20-30 years 7 (16)
30+ years 6 (14)
Employment status*
Full time 37 (86)




Lorch et al. BMC Infectious Diseases  (2015) 15:31 Page 3 of 8Interview guide
The semi structured interview guide was drafted, reviewed
and refined by ACCEPt research staff. The interviews cov-
ered the broad domains of GPs’ perceived facilitators and
barriers to chlamydia testing and management; the accept-
ability of ACCEPt to GPs; the perceived external and con-
textual factors affecting chlamydia testing rates and GPs’
self-reported chlamydia-related clinical practices. A num-
ber of questions related specifically to PNs’ current role in
preventative and sexual health and GPs’ opinions around
PN involvement in chlamydia testing and partner notifica-
tion. Demographic information was also collected.
Data collection and analysis
Interviews took place between March 2011 and July 2012,
were conducted via telephone, recorded and transcribed
verbatim. Data saturation was soon reached, but sampling
continued to include representation of GPs from all geo-
graphic areas in ACCEPt. The range of interview length
was from 20–35 minutes, with median length 30 minutes.
Data relating to PN involvement in chlamydia testing and
management were extracted from interview transcripts.
NVivo qualitative data analysis software (QSR Inter-
national Pty Ltd. Version 10, 2012) was used to organize
and code the data, which was thematically analysed using
a conventional content analysis approach [18]. A broad
coding framework was developed initially using the main
categories within the interview schedule. After multiple
readings of transcripts, this framework was refined and
data were grouped, labelled and emerging themes identi-
fied. Using analyst triangulation, interview transcripts
were independently coded by one author, and a sub-set
checked and compared by a second author to ensure con-
sensus on emergent themes.
Ethical approval
ACCEPt received ethical approval from the Royal Austra-
lian College of General Practitioners National Research and
Evaluation Ethics Committee, the Aboriginal Health and
Medical Research Council Ethics Committee and the
University of Melbourne Human Research Ethics Committee.
Results
Sixty three GPs were invited to participate and 44 agreed
(70%). Of the 44 GPs interviewed, 39 were from rural
areas in Victoria (15), New South Wales (11), Queens-
land (10), and South Australia (3), with 5 from urban
areas within Victoria. Table 1 shows characteristics of
participants. The themes identified during the interviews
were PNs’ current role in preventative and sexual health;
GPs’ support for PN involvement in chlamydia testing
and management; GP’s concerns regarding PN involve-
ment in chlamydia management, and education and
training for PNs.PNs’ current role in preventative and sexual health
Most of the GPs reported that PNs at their clinics were
involved in preventative health activities such as immun-
isation or, most commonly, related to chronic disease
management.
We do a diabetic clinic…a lot of that would cross over
into preventative health. Immunisations are preventative
as well, they do adult immunisations. GP65 (Rural).
A lot of the chronic disease management stuff is semi-
preventive in that we are trying to anticipate problems
that might arise in future and manage those through
things like diet and exercise, appropriate
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tions particularly in flu season. GP1 (Rural).
A number of GPs described how the PNs in their
clinics held a specialised role in women’s health, and
most PN involvement in sexual health occurred in the
context of activities related to this role, such as cervical
screening and well-woman checks.
When it comes to sexual health it would probably be
mostly limited to opportunistic prevention during Pap
smears because our nurse always takes histories and she
does the full deal not just the Pap smear. GP2 (Rural).
They mainly do women’s health checks where they do
Pap smears. They certainly would offer any screening
tests to any women that they thought it might
benefit. And I suppose generally we have offered it to
anyone under 40 but it depends on people’s lifestyle.
GP21 (Rural).
Many of the GPs felt that PNs could be utilised more
effectively for preventative health activities, including
sexual health, which was an area into which a few were
already expanding.
If we can broaden our preventive health campaign
to things outside diabetes and ischaemic heart disease
then we can incorporate a lot of other different
conditions and target healthy people more than we
are doing. At the moment we are mainly targeting
sick people. GP79 (Rural).
We are just about to start a young person’s sexual
health clinic. The plan is that she will see patients,
take histories and do chlamydia testing. We are just
about to expand her role because sexual health is
something she does well. GP18 (Rural).
GPs’ support for PN involvement in chlamydia testing and
management
All but one of the GPs expressed support for the idea of PNs
becoming more involved in chlamydia testing and manage-
ment. They felt that PNs were able to spend more time than
GPs with patients undertaking education and follow up.
I would love to work with a practice nurse who does
all our Pap smear and chlamydia tests… I am very
happy for that. I worked with nurse practitioners in
England I have no objection to them running their
own clinics. GP15 (Metro).
I think they do have time to spend with patients more
than we do, and therefore they can spend more time inexplaining the benefits of having something done and
also have more time for education and follow-up.
GP28 (Rural).
A number of GPs also believed that within the poten-
tially sensitive area of chlamydia management, patients
would feel more comfortable and less intimidated talking
to a PN.
Patients probably don’t find nurses as imposing as
speaking to their doctor…speaking to a nurse they
might be a bit more comfortable. GP34 (Rural).
I think it is easy for a nurse to talk to a patient especially
in a younger age group, to talk about such things because
patients probably relate a bit more to nurses… they have
a more gentle approach. GP60 (Rural).
A few GPs also thought that PN involvement may
benefit not only patients, but GPs also, offering some
relief to their considerable workloads.
That is definitely a good idea because we are under
pressure for time, so basically if we are running
around like always you know they could take part in
screening. GP72 (Rural).
It is helpful for the patient and doctor as well because
sometimes we are so busy. We don’t have enough time
to talk preventative health. For us, junior doctors,
maybe we have more time but I see the senior doctors,
they don’t have enough time. GP70 (Rural).
GPs’ concerns regarding PN involvement in chlamydia
management
Despite overwhelming support for the idea of increased
PN involvement in chlamydia management, a number of
concerns related to funding, PN workload and privacy/
confidentiality were voiced.
Funding and remuneration
Many of the GPs expressed concern around the funding
and remuneration of PN chlamydia management. It was
felt that the model of funding current at the time, re-
bates for specific activities performed by PNs, did not
fully cover the costs of PN activities and restricted ex-
pansion of their roles.
I think if the government was prepared to let us
raise the fee for nurse consultations that reflected
the time that they put in we would probably use
them for more. A lot of the time at the moment they
do things and we get no payment for their time.
GP29 (Rural).
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they do a lot of things themselves…A lot of the things
that the nurses could be doing here they don’t do
because of billing… we (GPs) get more money if we do
it. Definitely the nurses could play more of an active
role than they are but I think the reason that that
doesn’t happen so much is because of money and
billing. GP34 (Rural)
A specific item number for PN chlamydia management
was suggested as a means to cover the costs of the extra re-
sources needed for the activity, but as another GP pointed
out, PN item number rebates were often insufficient.
We could do it but then there would have to be funding
to actually make sure that we have got enough nurse
time available. I don’t know at this stage whether there
is an item number for this. It would actually have to be
an item number that made it worthwhile financially
because we are entirely dependent on the income.
GP21 (Rural).
Something like the rebate for a Pap smear does not
pay for their time…The rebate from memory is about
$12 to do a Pap smear and if they are doing a female
health check as part of the Pap smear that is a
45 minute consultation, so they are not even paying
their wage, so they can’t work independently. So we
don’t do it. GP8 (Rural).
Concerns around this area also went beyond Medicare
funding and to the issue of PNs working autonomously.
The question is should nurses be used that way?
They could but it comes back down to who pays
and if it is Medicare that pays then I am not so
sure that Medicare is very comfortable with nurses
initiating that and doctors signing off especially
when the doctor is not really involved in the care
of that patient. GP26 (Metro).
Workload and time pressures
Current workload and time pressures that PNs experi-
enced were factors discussed by some GPs when consid-
ering how PNs could increase involvement in chlamydia
management.
We see about on an average more than 100 patients
a day… we used to have another nurse come in twice
a week and she would do all the other things that our
main practice nurse wasn’t able to do. She has
stopped coming and that has been a terrible loss for
us…I think the nurses have a huge role to play and
we are probably depriving the community by nothaving another person to do that sort of thing. GP45
(Rural).
Again it is time…She is doing a good job but there are
huge loads. Yeah just the transfer of diabetes care into
general practice has swamped our nurse. So it leaves
little room for chlamydia! GP15 (Metro).
Privacy and confidentiality in small towns
Matters of privacy and confidentiality were brought up
by a number of GPs, with those in rural areas concerned
about the issues related to living in small country towns.
Possibly, I think one of the issues in a small town
like ourselves often patients are known and we would
just have to be careful that wasn’t a put off for the
patients. We would just have to be a little cognisant
of the fact that we live in a small community.
GP29 (Rural).
These concerns were voiced in particular around PNs’
involvement in partner notification.
I am not sure about that (partner notification).
I think is a difficult thing. There are issues involved
with that as far as confidentiality. If a person has
only got one partner and then you ring them up and
say, “You know we want to follow you up we think
you both have had some chlamydia contact,” well it
is pretty obvious who the person is that has been
here. GP28 (Rural).
I think it gets a bit difficult because in a country
town … one of our nurses had four children here
and they went to the local high school so their
children know a lot of people in town and I think
it would be a bit awkward if you had to ring up
someone and said, “Look you know…” And medico-
legally I mean confidentiality I always sort of
worryabout. GP4 (Rural).
Education and training for PNs
Many GPs felt that the provision of education and train-
ing, in both theory and practical skills, was an important
facilitator for PN involvement in chlamydia testing and
management.
I think they should have proper knowledge of
chlamydia… how can we treat it and do we
have to do any follow up after? If it’s complicated
chlamydia like PID, what is the management?
They should know more about it so they can
give proper health education to the patients.
GP20 (Rural).
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they are very unlikely to want to organise swabbing
because that requires the skills necessary for doing
virtually the equivalent of a Pap smear and some
nurses are comfortable with that and some are not.
But look they can be trained; it is undoubtedly easy
to train anyone up to that standard. GP26 (Metro).
I think they should be specifically trained to do that.
I think if the approach is on sexually transmitted
infections I think they would need to be trained for
that, the way they approach them, how they go
about the investigations. GP39 (Metro).
Discussion
The results of this first qualitative study of GP attitudes
and opinions regarding a PN role in chlamydia manage-
ment suggest that most GPs support PN involvement in
testing and partner notification and feel PNs are well
suited to the role. Despite GP support however, a number
of concerns were raised, such as PNs current workload
and time pressures, privacy and confidentiality issues in
small towns and in particular, the funding and remuner-
ation of PN activities in this area.
The potential contribution that PNs could make to in-
creasing chlamydia testing rates with an expansion of
their role in Australian general practice has previously
been highlighted [19,20]. Within the Australian public
hospital system it is being recognised that, as in the UK,
appropriate utilisation of the skills of nurses and expan-
sion of their role to undertake routine, low-risk proce-
dures usually performed by doctors could lead to
considerable financial savings and benefits for both pa-
tients and staff [21]. This can also apply within primary
healthcare, where workforce shortages and the increas-
ing burden of chronic disease are placing huge demands
on GPs. These demands necessitate a broader and more
flexible use of PNs’ skills if targets such as an increased
focus on preventative health and an increase in oppor-
tunities for priority groups, such as young people, to ac-
cess STI/chlamydia testing are to be realised [22].
The GPs in our study not only supported but recog-
nised the possible benefits of a PN role in chlamydia
management, such as a potential easing of their work-
load and improved patient service due to PNs better
rapport with patients. However, despite the positive
views expressed by our participants, recent research sug-
gests the attitudes of some GPs towards PN involvement
in sexual health may impede an extended role for PNs in
chlamydia testing. Abbott et al. [10] explored the in-
volvement of PNs in sexual health care and found that
whilst some GPs saw sexual health as a central compo-
nent of the PN role, others failed to recognise it as im-
portant. Furthermore, the PNs with an interest in sexualhealth felt constrained from utilising their skills due to
lack of GP recognition and support. The issue of GP at-
titudes as a significant barrier to PN involvement to
chlamydia testing was also raised in a series of inter-
views carried out with 23 PNs participating in ACCEPt
(Unpublished observations – Lorch). It has been sug-
gested by Abbott et al. that promotion of the PN role in
sexual health to not only GPs and PNs, but also govern-
ment, professional and educational organisations, may
serve to increase this support and recognition, raise
awareness and provide validation of the PN role [10].
A number of issues of concern that could act as poten-
tial barriers to PN involvement in chlamydia manage-
ment were identified by the GPs. Some felt that PNs
were experiencing the pressures of limited time and in-
creased workload that GPs themselves were facing. This
is a barrier consistently raised to chlamydia testing for
GPs both in Australia and the UK [23], and for Austra-
lian PNs themselves [12], but it is not insurmountable.
The provision of education and training for PNs, an im-
portant component of the ACCEPt PN intervention and
raised as a facilitator by our GPs, can incorporate exam-
ples of approaches to testing that PNs can implement in
their clinics to minimise time needed to undertake chla-
mydia testing consultations. These approaches may in-
volve the implementation of “chlamydia testing pathways”
aimed at streamlining and simplifying the testing process
and also the use of predetermined “scripts” when offering
and undertaking chlamydia testing with patients.
A number of the GPs in clinics in small rural towns
raised concerns about privacy and confidentiality, particu-
larly if PNs’ were involved in partner notification. They felt
that young patients may be “put off” if PNs and their fam-
ilies were known to them. A similar concern was also
raised by PNs participating in ACCEPt (unpublished ob-
servations - Lorch). Past research has demonstrated that
young people in small towns have the same concerns
[24,25]. However, results from a recent cross- sectional
chlamydia prevalence survey undertaken in mostly rural
Australian towns suggest that whilst young people may
have concerns around initiating testing, most find it ac-
ceptable to be offered a test, with 70% of the 16–29 years
olds approached during the survey agreeing to chlamydia
testing and 86% of these reporting that they were attend-
ing their local clinic [26].
The issue of remuneration and funding of PN involve-
ment in chlamydia testing, however, was of particular
concern to the GPs. The majority of the interviews were
undertaken whilst the previous fee-for-service PN fund-
ing model was still in operation. This model of funding,
as highlighted in the interviews, had drawbacks for both
the PN and the GP. The range of PN specific activities
that attracted a rebate was very narrow and in some
cases restricted the PN role to tasks that generated
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wide range of other activities that did not attract a rebate
and were therefore unfunded [27,28]. A specific PN chla-
mydia testing and management “item number”, which did
not exist at the time of the interviews, was suggested by
some GPs as a facilitator. This could not only ensure the
cost of PN time was funded, but also enable PNs to be au-
tonomously involved in the process of chlamydia testing
and management. Funding for PN involvement in a
“young person’s” preventative health check, which could
include screening for chlamydia/STIs and other psycho-
social risk behaviours, is another possibility. Recent re-
search has shown that general health checks among adults
are not effective in achieving improved patient health out-
comes [29]; however, evidence of the impact of preventa-
tive health screening of young people, and the role of the
PN in this area, is insufficient. The prevention access and
risk taking in young people (PARTY) project is an Austra-
lian cluster RCT which is currently evaluating an oppor-
tunistic preventative screening and brief counselling
intervention aimed at young people in general practice, in-
volving both GPs and PNs [30]. Early results suggest that
with appropriate training, and in collaboration with GPs,
PNs are able to conduct these preventive health checks
for young people and find this role acceptable [31,32].
The introduction of the new model of PN funding, the
PNIP, may also address the issue of funding for PN in-
volvement in chlamydia testing and management. The
replacement of a number of PN item numbers with a
single funding stream is a change which aims to support
an extended and enhanced role for PNs, enabling flexi-
bility for them to undertake a broader range of activities
(including prevention) based on patient and clinic need
rather than income generation. With no restrictions on
activities covered by funding, the PNIP may provide the
opportunity for PNs to be increasingly involved in chla-
mydia testing and management, freeing up time for GPs
to deal with more complex cases and increasing access
to testing for young people [33]. However, whilst imple-
mentation of the funding model is still in the early stages
and its impact on PN roles is yet to be formally evalu-
ated, it has been suggested that the PNIP may be seen
by GPs and practice managers as limiting the work PNs
can perform since there are no longer financial incen-
tives attached to “specific” activities [34]. Further work
may be needed to inform and support GPs and practice
managers in understanding how the scheme can work to
the advantage of not only themselves, but to PNs and
most importantly patients.
The strengths of this study include the recruitment of
GPs from a diverse range of clinics and locations across
Australia and a response rate of 70%. There are also
some limitations. The GPs who agreed to be interviewed
may represent a biased sample of GPs with a special“interest” in sexual health, and this bias may account for
the overwhelming support of PN involvement in chla-
mydia testing that the GPs in our study demonstrated.
Furthermore, the sample was drawn from GPs participat-
ing in ACCEPt who were from mostly rural and regional
areas. Abbott et al. found that PNs working in rural vs
metro settings had a stronger role in sexual health, and
were more supported in this role by GPs [10]. Although
the views of GPs from metro and rural settings were for
the most part similar, the issues unique to rural general
practice, such as ongoing workforce shortages and higher
rates of chronic disease than in metro areas [35,36] mean
that our study may not represent the views of all GPs
across Australia. Finally, as with most qualitative research,
the results are based on a relatively small sample size.
However, the purpose of qualitative research is to gain ei-
ther breadth or depth of opinion, in contrast to the pur-
pose of quantitative research which aims to describe the
frequency of such views. This study had a sample size of
44, which is high in terms of qualitative research. In
addition, a broad range of GPs was included in our sam-
ple, but despite this, data saturation (the point at which
no new data emerged) was reached early on in the inter-
viewing process, suggesting that their views were fairly
consistent.
Conclusion
In conclusion, untreated chlamydia infection may lead to
serious reproductive health issues for young people and is
thus a significant public health concern. The impact of in-
creasing chlamydia testing rates in general practice on the
burden of the disease in this population is currently being
investigated in Australia, with the role of the PN being in-
vestigated for the first time. Our study suggests that whilst
some GPs recognise and support the potentially valuable
contribution that PNs could make, barriers to PN involve-
ment in this area may impede progress. Further research
into the effectiveness and feasibility of PN chlamydia testing
is warranted, and in particular, the mechanism of funding
for a PN role in chlamydia testing and other areas of ex-
panded practice requires further consideration.
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